CoChat
Sign Up
Cited by 50

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development

Kim, Woojin Scott, Jary, Eve, Pickford, Russell, He, Ying, Ahmed, Rebekah M., Piguet, Olivier, Hodges, John R., Halliday, Glenda M.·2018·Frontiers in Neurology
DOI 10.3389/fneur.2018.00104PMC PMC5835505
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2018.00104

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cholesterol dysregulation and lipid dyshomeostasis have been identified in several neurodegenerative diseases.

    “Importantly, cholesterol dysregulation6–9 and lipid dyshomeostasis8,10–15 have been identified in several neurodegenerative diseases.”

    From GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau (2025) · cites this paper as [12]

  • Observed changes in cholesterol, CE, and lipid metabolism support previous observations of altered lipid metabolism in FTLD patient tissue samples, which may contribute to development of tau pathology at early stages.

    “The observed changes in cholesterol, CE, and lipid metabolism in this study support previous observations of altered lipid metabolism in FTLD patient tissue samples12,13,72, which may contribute to the development of tau pathology at the early stages of the disease.”

    From GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau (2025) · cites this paper as [12]

  • Previous studies have associated alterations of cholesterol and lipid metabolism in FTLD brain tissue and serum/plasma samples.

    “Previous studies have associated alterations of cholesterol and lipid metabolism in FTLD brain tissue72 and serum/plasma samples12,13.”

    From GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau (2025) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. Ratnavalli, 2002, The prevalence of frontotemporal dementia, Neurology, 58, 1615, 10.1212/WNL.58.11.1615 · DOI
  2. Piguet, 2011, Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management, Lancet Neurol, 10, 162, 10.1016/S1474-4422(10)70299-4 · DOI · Paper page
  3. Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  4. DeJesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011 · DOI · Paper page
  5. Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010 · DOI · Paper page
  6. Rohrer, 2009, The heritability and genetics of frontotemporal lobar degeneration, Neurology, 73, 1451, 10.1212/WNL.0b013e3181bf997a · DOI · Paper page
  7. Lashley, 2015, Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations, Neuropathol Appl Neurobiol, 41, 858, 10.1111/nan.12250 · DOI
  8. Fernandez-Matarrubia, 2015, Biomarkers: a new approach to behavioural variant frontotemporal dementia, Neurologia, 30, 50, 10.1016/j.nrl.2013.03.002 · DOI
  9. Broe, 2003, Staging disease severity in pathologically confirmed cases of frontotemporal dementia, Neurology, 60, 1005, 10.1212/01.WNL.0000052685.09194.39 · DOI
  10. Kril, 2004, Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy, Dement Geriatr Cogn Disord, 17, 311, 10.1159/000077161 · DOI
  11. Kril, 2005, Distribution of brain atrophy in behavioral variant frontotemporal dementia, J Neurol Sci, 232, 83, 10.1016/j.jns.2005.02.003 · DOI · Paper page
  12. Gregory, 2006, Differences in regional brain atrophy in genetic forms of Alzheimer’s disease, Neurobiol Aging, 27, 387, 10.1016/j.neurobiolaging.2005.03.011 · DOI
  13. O’Brien, 1965, Lipid composition of the normal human brain: gray matter, white matter, and myelin, J Lipid Res, 6, 537, 10.1016/S0022-2275(20)39619-X · DOI · Paper page
  14. Rascovsky, 2011, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, 134, 2456, 10.1093/brain/awr179 · DOI · Paper page
  15. Ahmed, 2014, Quantifying the eating abnormalities in frontotemporal dementia, JAMA Neurol, 71, 1540, 10.1001/jamaneurol.2014.1931 · DOI · Paper page
  16. Ahmed, 2014, Systemic metabolism in frontotemporal dementia, Neurology, 83, 1812, 10.1212/WNL.0000000000000993 · DOI · Paper page
  17. McKhann, 2011, Changing concepts of Alzheimer disease, JAMA, 305, 2458, 10.1001/jama.2011.810 · DOI
  18. Castro-Perez, 2010, Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients, J Proteome Res, 9, 2377, 10.1021/pr901094j · DOI
  19. Whitwell, 2007, VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration, Neuroimage, 35, 207, 10.1016/j.neuroimage.2006.12.006 · DOI
  20. Ahmed, 2015, Eating behavior in frontotemporal dementia: peripheral hormones vs hypothalamic pathology, Neurology, 85, 1310, 10.1212/WNL.0000000000002018 · DOI
  21. Parks, 2002, Dietary carbohydrate’s effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations, Br J Nutr, 87, S247, 10.1079/BJN/2002544 · DOI
  22. Nestel, 1965, Mechanism of alcohol-induced hypertriglyceridemia, J Lab Clin Med, 66, 357
  23. Bessembinders, 2011, Severe hypertriglyceridemia influenced by alcohol (SHIBA), Alcohol Alcohol, 46, 113, 10.1093/alcalc/agq088 · DOI
  24. Frisardi, 2010, Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer’s disease, Ageing Res Rev, 9, 399, 10.1016/j.arr.2010.04.007 · DOI
  25. Panza, 2010, Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms, J Alzheimers Dis, 21, 691, 10.3233/JAD-2010-091669 · DOI
  26. Pietilainen, 2007, Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects – a monozygotic twin study, PLoS One, 2, e218, 10.1371/journal.pone.0000218 · DOI
  27. Cenacchi, 1993, Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration, Aging (Milano), 5, 123
  28. Cunnane, 2012, Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer’s disease, J Alzheimers Dis, 29, 691, 10.3233/JAD-2012-110629 · DOI
  29. Svennerholm, 1968, Distribution and fatty acid composition of phosphoglycerides in normal human brain, J Lipid Res, 9, 570, 10.1016/S0022-2275(20)42702-6 · DOI
  30. Hayes, 1976, Synthesis and turnover of cerebrosides and phosphatidylserine of myelin and microsomal fractions of adult and developing rat brain, Biochem J, 160, 195, 10.1042/bj1600195 · DOI
  31. Toffano, 1978, Modification of noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes, Life Sci, 23, 1093, 10.1016/0024-3205(78)90671-9 · DOI
  32. Vannucchi, 1987, Effect of phosphatidylserine on acetylcholine release and content in cortical slices from aging rats, Neurobiol Aging, 8, 403, 10.1016/0197-4580(87)90034-0 · DOI · Paper page
  33. Casamenti, 1991, Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study, Eur J Pharmacol, 194, 11, 10.1016/0014-2999(91)90117-9 · DOI
  34. Drago, 1981, Behavioral effects of phosphatidylserine in aged rats, Neurobiol Aging, 2, 209, 10.1016/0197-4580(81)90023-3 · DOI
  35. Corwin, 1985, Behavioral effects of phosphatidylserine in the aged Fischer 344 rat: amelioration of passive avoidance deficits without changes in psychomotor task performance, Neurobiol Aging, 6, 11, 10.1016/0197-4580(85)90065-X · DOI
  36. Suzuki, 2001, Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats, J Nutr, 131, 2951, 10.1093/jn/131.11.2951 · DOI
  37. Aporti, 1986, Age-dependent spontaneous EEG bursts in rats: effects of brain phosphatidylserine, Neurobiol Aging, 7, 115, 10.1016/0197-4580(86)90149-1 · DOI
  38. Rosadini, 1990, Phosphatidylserine: quantitative EEG effects in healthy volunteers, Neuropsychobiology, 24, 42, 10.1159/000119041 · DOI
  39. Cole, 2012, Phosphatidylcholine biosynthesis and lipoprotein metabolism, Biochim Biophys Acta, 1821, 754, 10.1016/j.bbalip.2011.09.009 · DOI
  40. Ewers, 2010, Blood-based biomarkers of microvascular pathology in Alzheimer’s disease, Exp Gerontol, 45, 75, 10.1016/j.exger.2009.09.005 · DOI
  41. Hammad, 2010, Blood sphingolipidomics in healthy humans: impact of sample collection methodology, J Lipid Res, 51, 3074, 10.1194/jlr.D008532 · DOI
  42. Scherer, 2011, Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry, Biochim Biophys Acta, 1811, 68, 10.1016/j.bbalip.2010.11.003 · DOI
  43. Han, 2012, Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses, Mass Spectrom Rev, 31, 134, 10.1002/mas.20342 · DOI
  44. Reis, 2013, A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL, J Lipid Res, 54, 1812, 10.1194/jlr.M034330 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kim, W. S., Jary, E., Pickford, R., He, Y., Ahmed, R. M., Piguet, O., Hodges, J. R., & Halliday, G. M.
Venue
Frontiers in Neurology
Publisher
Frontiers Media SA
Published
2018-02-28
Volume
9
ISSN
1664-2295
DOI
10.3389/fneur.2018.00104
PMC
PMC5835505
Cited by
50
References
4
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review